SEVERE FLUOROURACIL TOXICITY IN A PATIENT WITH DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY

被引：52

作者：

HOUYAU, P ^{[1
]}

GAY, C ^{[1
]}

CHATELUT, E ^{[1
]}

CANAL, P ^{[1
]}

ROCHE, H ^{[1
]}

MILANO, G ^{[1
]}

机构：

[1] CTR ANTOINE LACASSAGNE,F-06054 NICE,FRANCE

来源：

关键词：

D O I：

10.1093/jnci/85.19.1602

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1602 / 1603

页数：2

共 12 条

[1] FAMILIAL DEFICIENCY OF DIHYDROPYRIMIDINE DEHYDROGENASE - BIOCHEMICAL BASIS FOR FAMILIAL PYRIMIDINEMIA AND SEVERE 5-FLUOROURACIL-INDUCED TOXICITY
DIASIO, RB
BEAVERS, TL
CARPENTER, JT
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) : 47 - 51
[2] CLINICAL-PHARMACOLOGY OF 5-FLUOROURACIL
DIASIO, RB
HARRIS, BE
[J]. CLINICAL PHARMACOKINETICS, 1989, 16 (04) : 215 - 237
[3] FLEMING RA, 1993, EUR J CANCER, V29A, P740
[4] FLEMING RA, 1992, CANCER RES, V52, P2889
[5] HARRIS BE, 1991, CANCER, V68, P499, DOI 10.1002/1097-0142(19910801)68:3<499::AID-CNCR2820680309>3.0.CO
[6] 2-F
[7] HARRIS BE, 1990, CANCER RES, V50, P197
[8] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[9] 2-6
[10] THYSS A, 1986, CANCER CHEMOTH PHARM, V16, P64